Pages that link to "Q50668961"

The following pages link to Direct medical cost of chronic obstructive pulmonary disease in the U.S.A. (Q50668961):

Displaying 28 items.

• Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data (Q31082713) (← links)
• Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice (Q33866072) (← links)
• Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease (Q34042468) (← links)
• An economic overview of chronic obstructive pulmonary disease (Q34309884) (← links)
• Incidence and cost of pneumonia in older adults with COPD in the United States (Q35018421) (← links)
• A novel method for extracting respiration rate and relative tidal volume from infrared thermography (Q35022327) (← links)
• Treatment of chronic obstructive pulmonary disease in older patients: a practical guide (Q35063689) (← links)
• Patient selection for lung volume reduction surgery (Q35610409) (← links)
• Present and future costs of COPD in Iceland and Norway: results from the BOLD study (Q35906562) (← links)
• Statement on home care for patients with respiratory disorders (Q36154887) (← links)
• The economics of topical immunomodulators for the treatment of atopic dermatitis. (Q36165229) (← links)
• Provider adherence to COPD guidelines: relationship to organizational factors (Q36191243) (← links)
• Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan. (Q36732324) (← links)
• Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature (Q36760100) (← links)
• COPD--the primary care perspective: addressing epidemiology, pathology, diagnosis, treatment of smoking's multiple morbidities and the patient's perspective (Q36761477) (← links)
• Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery (Q36889990) (← links)
• Cost-effectiveness of smoking cessation and the implications for COPD. (Q37018832) (← links)
• Role of macrolide therapy in chronic obstructive pulmonary disease (Q37319950) (← links)
• DERIVATION OF A TEST STATISTIC FOR EMPHYSEMA QUANTIFICATION. (Q37496676) (← links)
• Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population (Q43884681) (← links)
• Utilization of health care services by patients with chronic obstructive pulmonary disease (Q44300898) (← links)
• Economic burden of chronic obstructive pulmonary disease. (Q45388291) (← links)
• Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone (Q46456967) (← links)
• Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease (Q47656205) (← links)
• Lower respiratory tract infections: impact on the workplace (Q47801543) (← links)
• Cost differences for COPD with and without physician-diagnosis. (Q50793757) (← links)
• Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease (Q51716023) (← links)
• The economic burden of supportive care of cancer patients (Q75438015) (← links)